| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/21/2013 | CN101721569B New method for evaluating quality of finished product of JEY lotion |
| 08/21/2013 | CN101591322B Cyclin dependent kinases inhibitor scutellaria flavonoid organic amine derivatives, preparation method and application thereof |
| 08/21/2013 | CN101389323B Pharmaceutical composition comprising oseltamivir phosphate |
| 08/21/2013 | CN101273028B Macrocyclic inhibitors of hepatitis C virus |
| 08/20/2013 | US8513381 Melanocortin analogs with antimicrobial activity |
| 08/20/2013 | US8513296 Pharmaceutical composition |
| 08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 08/20/2013 | US8513261 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 08/20/2013 | US8513255 Substituted dihydroquinazolines |
| 08/20/2013 | US8513231 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 08/20/2013 | US8513184 Macrocyclic inhibitors of flaviviridae viruses |
| 08/20/2013 | US8512767 Pharmaceutical compositions |
| 08/20/2013 | US8512718 Pharmaceutical composition for topical application |
| 08/20/2013 | CA2698825C Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection |
| 08/20/2013 | CA2620125C Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 08/20/2013 | CA2569729C Peptidomimetic inhibitors of retroviral proteases and their use as antivirals |
| 08/20/2013 | CA2559036C 9-substituted 8-oxoadenine compound |
| 08/20/2013 | CA2492333C Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/20/2013 | CA2407301C Hsp60 sequence from piscirickettsia salmonis |
| 08/15/2013 | WO2013119683A1 Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses |
| 08/15/2013 | WO2013119668A1 Mucins as antiviral compounds |
| 08/15/2013 | WO2013119542A1 Compounds for the treatment of hepatitis c |
| 08/15/2013 | WO2013119508A1 Adhesive patch with antimicrobial composition |
| 08/15/2013 | WO2013119499A1 Novel compounds for the treatment of hepatitis c |
| 08/15/2013 | WO2013118102A1 Antiviral compounds with a heterotricycle moiety |
| 08/15/2013 | WO2013118097A1 Antiviral compounds with a dibenzooxaheterocycle moiety |
| 08/15/2013 | WO2013117986A1 Pyrroloquinoline alkaloids as antimalarial agents and process for the preparation thereof |
| 08/15/2013 | WO2013117749A1 Pyrrolic derivatives, processes for preparing the same and their uses as a drug |
| 08/15/2013 | WO2013117735A1 Conjugate comprising an agent and an antiviral ligand and its use in a method for delivering the agent intracellularly |
| 08/15/2013 | WO2013117615A1 Piperidino-pyrimidine derivatives for the treatment of viral infections |
| 08/15/2013 | WO2013117559A1 Thiamine derivatives and their use as antibiotics |
| 08/15/2013 | WO2013117348A1 Agonists and antagonists of toll-like receptor (tlr) 13 |
| 08/15/2013 | WO2013117137A1 Lupane triterpenoid derivatives and pharmaceutical use thereof |
| 08/15/2013 | WO2013116965A1 Combined antigen and dna vaccine for preventing and treating rsv infection |
| 08/15/2013 | WO2013078250A3 Cystine knot peptides that bind alpha-v-beta-6 integrin |
| 08/15/2013 | WO2013030670A3 Tissue targeted fusobacterium antigenic activation of the immune response to treat intestinal cancers |
| 08/15/2013 | WO2013029634A3 Natural antioxidant anti-influenza composition |
| 08/15/2013 | US20130211368 Microfabricated nanopore device for sustained release of therapeutic agent |
| 08/15/2013 | US20130209592 Plant Extract Based Compositions and Methods For Treating Chronic Wounds |
| 08/15/2013 | US20130209516 Immunomodulatory compositions |
| 08/15/2013 | US20130209456 Subtypes of humanized antibody against interleukin-6 receptor |
| 08/15/2013 | US20130209408 Bacteriophage-containing therapeutic agents |
| 08/15/2013 | US20130209395 Nucleic acid molecule encoding hepatitis b virus core protein and surface antigen protein and vaccine comprising the same |
| 08/14/2013 | EP2626425A1 Influenza virus neutralizing antibody and method for screening same |
| 08/14/2013 | EP2626361A1 Pyrrole antifungal agents |
| 08/14/2013 | EP2626357A1 Pyrrolic derivatives, processes for preparing the same and their uses as antibiotics |
| 08/14/2013 | EP2626356A1 Thiamine analogues and their use as antibiotics |
| 08/14/2013 | EP2626349A1 Amine compound and use for same |
| 08/14/2013 | EP2625190A2 Derivatives of steroid benzylamines, having an antiparasitic, antibacterial, antimycotic and/or antiviral action |
| 08/14/2013 | EP2625181A2 Method of preparation of antiviral compounds and useful intermediates thereof |
| 08/14/2013 | EP2625178A1 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls |
| 08/14/2013 | EP2625174A1 Co-crystals and salts of ccr3-inhibitors |
| 08/14/2013 | EP2624841A1 Compositions for treating chronic viral infections |
| 08/14/2013 | EP2624840A1 New treatments of hepatitis c virus infection |
| 08/14/2013 | EP2624826A1 Vitamin e formulations of sulfamide ns3 inhibitors |
| 08/14/2013 | EP2624820A2 Antimicrobial preservation of propofol emulsions |
| 08/14/2013 | EP2624817A1 Novel composition |
| 08/14/2013 | CN203123075U Photochromic anti-acne repair membrane sheet |
| 08/14/2013 | CN203123074U Antibacterial health-care mask |
| 08/14/2013 | CN1615141B Use of polysaccharide derivatives as anti-infective substances |
| 08/14/2013 | CN103249732A Bacteria topoisomerase II inhibiting 2-thylcarbamoylamino-1, 3-benzothiazol-5-yls |
| 08/14/2013 | CN103249731A Hepatitis c virus inhibitors |
| 08/14/2013 | CN103249726A Acylbenzene derivative |
| 08/14/2013 | CN103249402A Novel composition |
| 08/14/2013 | CN103246812A Radio frequency identification device (RFID) system powered by lithium ion battery and used for storing individual tuberculosis information |
| 08/14/2013 | CN103243098A RelA cut and TLR7 active sequence modified locked nucleic acid deoxyribozyme for targeted therapy of tuberculosis and application thereof |
| 08/14/2013 | CN103243072A Method for amplifying and activating lymphocyte cells by CD 8 alpha-interleukin 21 fragment-CD137 complex |
| 08/14/2013 | CN103243041A Bacillus licheniformis H2 and application thereof |
| 08/14/2013 | CN103242452A Method for amplifying lymphocytes by using interleukin 15 receptor segment-interleukin 2 compound |
| 08/14/2013 | CN103242448A Full-humanized anti-PD-1 monoclonal antibody and preparation method and application thereof |
| 08/14/2013 | CN103242434A Method for preparing acellular pertussis vaccine |
| 08/14/2013 | CN103242427A CTL epitope polypeptide of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof |
| 08/14/2013 | CN103242426A Avian influenza virus H5N1 subtype restrictive CTL epitope polypeptide and application thereof |
| 08/14/2013 | CN103242420A Friedelane lactone compound and preparation method as well as application thereof |
| 08/14/2013 | CN103242419A Friedelane triterpenoid and preparation method as well as application thereof |
| 08/14/2013 | CN103242416A Seco-friedelolactone triterpenoid and preparation method as well as application thereof |
| 08/14/2013 | CN103242413A Lupane triterpenoid derivative and pharmaceutical application thereof |
| 08/14/2013 | CN103242400A 5-substituted pyrimidine nucleoside-thiazolidinone hybrid with anti-HIV activity and preparation method thereof |
| 08/14/2013 | CN103242392A Novel glycyrrhizic acid double salt, and preparation and application thereof |
| 08/14/2013 | CN103242366A Tenofovir disoproxil fumarate compounds, preparation method and application to antiviral field |
| 08/14/2013 | CN103242363A Florfenicol phosphate diester and salt, and preparation method for same |
| 08/14/2013 | CN103242341A Thieno 2,4-substituted pyrimidine compound, and pharmaceutical composition and application thereof |
| 08/14/2013 | CN103242336A Gambogic acid-type derivative and preparation and application thereof |
| 08/14/2013 | CN103242332A 1-N acyl substituted indolone derivative |
| 08/14/2013 | CN103242301A 5-hydrogenation benzopyran substituted pyrimidine carbocyclic ring nucleoside and preparation method |
| 08/14/2013 | CN103242259A 2-(carbonyl-N-phenothiazinyl)-benzoic acid and preparation method thereof |
| 08/14/2013 | CN103242242A 5-electron-defect alkenyl substituted pyrimidine carbocyclic ring nucleoside and preparation method |
| 08/14/2013 | CN103242210A Mulin acetate containing substituted squaric acid and application thereof |
| 08/14/2013 | CN103239734A Vaccine for prevention and/or treatment of respiratory syncytial virus infection |
| 08/14/2013 | CN103239730A Medical sodium alginate gel microsphere and preparation method and application thereof |
| 08/14/2013 | CN103239717A Replicon DNA (Deoxyribonucleic Acid) vaccine for treating chronic hepatitis B |
| 08/14/2013 | CN103239712A HIV (human immunodeficiency virus) microbicide and application thereof |
| 08/14/2013 | CN103239705A Composition for crocodile collagen antibacterial peptide and preparation method thereof |
| 08/14/2013 | CN103239684A Zedoary oil injection and preparation method thereof |
| 08/14/2013 | CN103239676A Topical pharmaceutical composition for preventing and treating bacterial vaginosis |
| 08/14/2013 | CN103239667A Chinese traditional medicine for treating foot-and-mouth disease of domestic animals |
| 08/14/2013 | CN103239665A Traditional Chinese medicine composition for treating sepsis |
| 08/14/2013 | CN103239664A Traditional Chinese medicine for preventing hand-foot-and-mouth disease |
| 08/14/2013 | CN103239663A Drug for preventing influenza |